GE HealthCare Technologies revenue and financials
$64.77Change from previous close: −1.48%Absolute change: −$0.97
In the fiscal year ended December 2025, GE HealthCare Technologies reported revenue of $20.63B (+4.84% year over year). Net income was $2.08B, a net margin of 10.1%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +4.84%
- 2025 vs 2024
- Net income growth
- +4.57%
- 2025 vs 2024
- Net margin
- 10.1%
- 2024: 10.1%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 20,625 | 19,672 | 19,552 | 18,341 | 17,585 |
| Cost of revenue | 12,378 | 11,467 | 11,630 | 11,162 | 10,411 |
| Gross profit | 8,247 | 8,205 | 7,922 | 7,179 | 7,174 |
| Selling, general and administrative | 3,923 | 3,849 | 3,889 | 3,686 | 3,564 |
| Research and development | 1,260 | 1,311 | 1,205 | 1,026 | 816 |
| Operating income | 3,064 | 3,045 | 2,828 | 2,467 | 2,794 |
| EBIT | 3,064 | 3,045 | 2,828 | 2,467 | 2,794 |
| EBITDA | 3,642 | 3,625 | 3,438 | 3,100 | 3,419 |
| Interest expense | 381 | 463 | 542 | 86.0 | 40.0 |
| Pre-tax income | 2,768 | 2,581 | 2,361 | 2,512 | 2,875 |
| Income tax | 614 | 531 | 743 | 563 | 600 |
| Net income | 2,084 | 1,993 | 1,385 | 1,916 | 2,247 |
| Net income to common shareholders | 2,084 | 1,993 | 1,385 | 1,916 | 2,247 |
| Basic EPS | 4.57 | 4.37 | 3.04 | 4.22 | 4.95 |
| Diluted EPS | 4.55 | 4.34 | 3.03 | 4.22 | 4.95 |
| Average shares (basic) | 456 | 456 | 455 | 454 | 454 |
| Average shares (diluted) | 458 | 459 | 458 | 454 | 454 |
| Dividend per share | 0.14 | 0.13 | 0.12 | — | — |